General Information of Drug (ID: DMWW830)

Drug Name
RG7637
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Phase 1 [1]
Cross-matching ID
TTD ID
DXVD02

References

1 Clinical pipeline report, company report or official report of Roche